Screens the MSCI World Index to identify leading companies. Selects top-performing companies from each country by industry. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
No real growth (2% a year). Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
Executives buying with their own money is usually read as confidence in the company’s future.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
Sales run at $255.0M a year. A small number, but proof the product has real buyers.
Over the last 12 months, company executives reported 41 buys and 26 sells. Management buying with its own money is usually read as a good sign.
It pays out $0.21 per share each year — regular cash for whoever holds the stock.
A loss of $119.7M against $255.0M in annual sales.
At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.
We grade companies — revenue, margins, balance sheets. This is a fund, so there is no report card to give. That is not a low grade; it is a different kind of thing.
One-line summary: a basket, not a business. Judge it by what it holds.